Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Valneva
Fierce Biotech
Valneva to lay off up to 15%, faces tough travel vaccine market
Valneva is planning to shrink its headcount by up to 15% as the French vaccine developer continues to seek ways to cut costs.
James Waldron
May 13, 2026 8:35am
Valneva pulls chikungunya vaccine Ixchiq in US
Jan 20, 2026 10:41am
Fierce Biotech
Valneva closes site to consolidate R&D footprint, lays off 30
Nov 26, 2025 12:57pm
After lifting pause, FDA suspends use of Valneva's Ixchiq
Aug 25, 2025 11:29am
FDA lifts pause of Valneva's chikungunya vaccine in older adults
Aug 7, 2025 10:42am
FDA, CDC call for pause of chikungunya shot rollout in seniors
May 12, 2025 9:52am
